150 related articles for article (PubMed ID: 19103205)
1. Structural insights into the association between BCAR3 and Cas family members, an atypical complex implicated in anti-oestrogen resistance.
Garron ML; Arsenieva D; Zhong J; Bloom AB; Lerner A; O'Neill GM; Arold ST
J Mol Biol; 2009 Feb; 386(1):190-203. PubMed ID: 19103205
[TBL] [Abstract][Full Text] [Related]
2. Dimerization of the docking/adaptor protein HEF1 via a carboxy-terminal helix-loop-helix domain.
Law SF; Zhang YZ; Fashena SJ; Toby G; Estojak J; Golemis EA
Exp Cell Res; 1999 Oct; 252(1):224-35. PubMed ID: 10502414
[TBL] [Abstract][Full Text] [Related]
3. Molecular determinants for interaction of SHEP1 with Cas localize to a highly solvent-protected region in the complex.
Derunes C; Burgess R; Iraheta E; Kellerer R; Becherer K; Gessner CR; Li S; Hewitt K; Vuori K; Pasquale EB; Woods VL; Ely KR
FEBS Lett; 2006 Jan; 580(1):175-8. PubMed ID: 16364304
[TBL] [Abstract][Full Text] [Related]
4. Crk-associated substrate p130(Cas) interacts with nephrocystin and both proteins localize to cell-cell contacts of polarized epithelial cells.
Donaldson JC; Dempsey PJ; Reddy S; Bouton AH; Coffey RJ; Hanks SK
Exp Cell Res; 2000 Apr; 256(1):168-78. PubMed ID: 10739664
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer anti-estrogen resistance 3 (BCAR3) protein augments binding of the c-Src SH3 domain to Crk-associated substrate (p130cas).
Makkinje A; Vanden Borre P; Near RI; Patel PS; Lerner A
J Biol Chem; 2012 Aug; 287(33):27703-14. PubMed ID: 22711540
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis for regulation of Src by the docking protein p130Cas.
Nasertorabi F; Tars K; Becherer K; Kodandapani R; Liljas L; Vuori K; Ely KR
J Mol Recognit; 2006; 19(1):30-8. PubMed ID: 16245368
[TBL] [Abstract][Full Text] [Related]
7. NSP-Cas protein structures reveal a promiscuous interaction module in cell signaling.
Mace PD; Wallez Y; Dobaczewska MK; Lee JJ; Robinson H; Pasquale EB; Riedl SJ
Nat Struct Mol Biol; 2011 Nov; 18(12):1381-7. PubMed ID: 22081014
[TBL] [Abstract][Full Text] [Related]
8. The substrate domain of BCAR1 is essential for anti-estrogen-resistant proliferation of human breast cancer cells.
Brinkman A; de Jong D; Tuinman S; Azaouagh N; van Agthoven T; Dorssers LC
Breast Cancer Res Treat; 2010 Apr; 120(2):401-8. PubMed ID: 19412734
[TBL] [Abstract][Full Text] [Related]
9. Regulation of T-lymphocyte physiology by the Chat-H/CasL adapter complex.
Alexandropoulos K; Regelmann AG
Immunol Rev; 2009 Nov; 232(1):160-74. PubMed ID: 19909363
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of human enhancer of filamentation (HEF1) on serine 369 induces its proteasomal degradation.
Hivert V; Pierre J; Raingeaud J
Biochem Pharmacol; 2009 Oct; 78(8):1017-25. PubMed ID: 19539609
[TBL] [Abstract][Full Text] [Related]
11. Expression and tyrosine phosphorylation of Crk-associated substrate lymphocyte type (Cas-L) protein in human neutrophils.
Nakamoto T; Seo S; Sakai R; Kato T; Kutsuna H; Kurokawa M; Noda M; Miyasaka N; Kitagawa S
J Cell Biochem; 2008 Sep; 105(1):121-8. PubMed ID: 18465784
[TBL] [Abstract][Full Text] [Related]
12. BCAR3 regulates EGF-induced DNA synthesis in normal human breast MCF-12A cells.
Oh MJ; van Agthoven T; Choi JE; Jeong YJ; Chung YH; Kim CM; Jhun BH
Biochem Biophys Res Commun; 2008 Oct; 375(3):430-4. PubMed ID: 18722344
[TBL] [Abstract][Full Text] [Related]
13. p130Cas regulates the activity of AND-34, a novel Ral, Rap1, and R-Ras guanine nucleotide exchange factor.
Gotoh T; Cai D; Tian X; Feig LA; Lerner A
J Biol Chem; 2000 Sep; 275(39):30118-23. PubMed ID: 10896938
[TBL] [Abstract][Full Text] [Related]
14. The SH2 domain protein Shep1 regulates the in vivo signaling function of the scaffolding protein Cas.
Roselli S; Wallez Y; Wang L; Vervoort V; Pasquale EB
Cell Signal; 2010 Nov; 22(11):1745-52. PubMed ID: 20603213
[TBL] [Abstract][Full Text] [Related]
15. BCAR3/AND-34 can signal independent of complex formation with CAS family members or the presence of p130Cas.
Vanden Borre P; Near RI; Makkinje A; Mostoslavsky G; Lerner A
Cell Signal; 2011 Jun; 23(6):1030-40. PubMed ID: 21262352
[TBL] [Abstract][Full Text] [Related]
16. SHP-2 inhibits tyrosine phosphorylation of Cas-L and regulates cell migration.
Yo K; Iwata S; Hashizume Y; Kondo S; Nomura S; Hosono O; Kawasaki H; Tanaka H; Dang NH; Morimoto C
Biochem Biophys Res Commun; 2009 Apr; 382(1):210-4. PubMed ID: 19275884
[TBL] [Abstract][Full Text] [Related]
17. Organization of functional domains in the docking protein p130Cas.
Nasertorabi F; Garcia-Guzman M; Briknarová K; Larsen E; Havert ML; Vuori K; Ely KR
Biochem Biophys Res Commun; 2004 Nov; 324(3):993-8. PubMed ID: 15485652
[TBL] [Abstract][Full Text] [Related]
18. Nedd9/Hef1/Cas-L mediates the effects of environmental pollutants on cell migration and plasticity.
Bui LC; Tomkiewicz C; Chevallier A; Pierre S; Bats AS; Mota S; Raingeaud J; Pierre J; Diry M; Transy C; Garlatti M; Barouki R; Coumoul X
Oncogene; 2009 Oct; 28(41):3642-51. PubMed ID: 19648964
[TBL] [Abstract][Full Text] [Related]
19. Crk-associated substrate (Cas) family member, NEDD9, is regulated in human neuroblastoma cells and in the embryonic hindbrain by all-trans retinoic acid.
Merrill RA; See AW; Wertheim ML; Clagett-Dame M
Dev Dyn; 2004 Nov; 231(3):564-75. PubMed ID: 15376324
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine Y189 in the substrate domain of the adhesion docking protein NEDD9 is conserved with p130Cas Y253 and regulates NEDD9-mediated migration and focal adhesion dynamics.
Baquiran JB; Bradbury P; O'Neill GM
PLoS One; 2013; 8(7):e69304. PubMed ID: 23874939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
